Bacillus calmete-guerin plus interferon- 2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity

Author: Lam J.S.   Benson M.C.   O'Donnell M.A.   Sawczuk A.   Gavazzi A.   Wechsler M.H.   Sawczuk I.S.  

Publisher: Elsevier

ISSN: 1078-1439

Source: Urologic Oncology: Seminars and Original Investigations, Vol.21, Iss.5, 2003-09, pp. : 354-360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content